(Q34224524)

31 July 2017

Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials (English)

1 reference

31 July 2017

1 reference

McKenna SP

1

1 reference

31 July 2017

Cook SA

2

1 reference

31 July 2017

Whalley D

3

1 reference

31 July 2017

Doward LC

4

1 reference

31 July 2017

Richards HL

5

1 reference

31 July 2017

Griffiths CE

6

1 reference

31 July 2017

Van Assche D

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

British Journal of Dermatology

31 July 2017

1 reference

31 July 2017

149

1 reference

31 July 2017

2

1 reference

31 July 2017

323-331

1 reference

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05492.X

The QLDS: a scale for the measurement of quality of life in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05492.X

The international development of the RGHQoL: a quality of life measure for recurrent genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05492.X

Quality of life in depression scale (QLDS). Development, reliability, validity, responsiveness and application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05492.X

The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05492.X

The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05492.X

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05492.X

10.1046/J.1365-2133.2003.05492.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference